1. Home
  2. IMAB vs SQNS Comparison

IMAB vs SQNS Comparison

Compare IMAB & SQNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • SQNS
  • Stock Information
  • Founded
  • IMAB 2014
  • SQNS 2003
  • Country
  • IMAB United States
  • SQNS France
  • Employees
  • IMAB N/A
  • SQNS N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • SQNS Semiconductors
  • Sector
  • IMAB Health Care
  • SQNS Technology
  • Exchange
  • IMAB Nasdaq
  • SQNS Nasdaq
  • Market Cap
  • IMAB 200.9M
  • SQNS 46.5M
  • IPO Year
  • IMAB 2020
  • SQNS 2011
  • Fundamental
  • Price
  • IMAB $2.16
  • SQNS $1.42
  • Analyst Decision
  • IMAB Strong Buy
  • SQNS Strong Buy
  • Analyst Count
  • IMAB 2
  • SQNS 1
  • Target Price
  • IMAB $6.00
  • SQNS $7.50
  • AVG Volume (30 Days)
  • IMAB 982.8K
  • SQNS 1.0M
  • Earning Date
  • IMAB 05-15-2025
  • SQNS 08-22-2025
  • Dividend Yield
  • IMAB N/A
  • SQNS N/A
  • EPS Growth
  • IMAB N/A
  • SQNS N/A
  • EPS
  • IMAB N/A
  • SQNS 2.16
  • Revenue
  • IMAB N/A
  • SQNS $38,858,000.00
  • Revenue This Year
  • IMAB N/A
  • SQNS N/A
  • Revenue Next Year
  • IMAB N/A
  • SQNS $93.87
  • P/E Ratio
  • IMAB N/A
  • SQNS $0.66
  • Revenue Growth
  • IMAB N/A
  • SQNS 40.06
  • 52 Week Low
  • IMAB $0.60
  • SQNS $0.95
  • 52 Week High
  • IMAB $3.08
  • SQNS $4.28
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 50.70
  • SQNS 36.54
  • Support Level
  • IMAB $2.00
  • SQNS $1.40
  • Resistance Level
  • IMAB $2.95
  • SQNS $1.51
  • Average True Range (ATR)
  • IMAB 0.34
  • SQNS 0.20
  • MACD
  • IMAB -0.08
  • SQNS -0.04
  • Stochastic Oscillator
  • IMAB 15.79
  • SQNS 15.89

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About SQNS Sequans Communications S.A.

Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its offer 5G/4G chips and modules fully optimized for non-smartphone devices. The company covers applications such as smart mobility and logistics, smart utility meters, smart cities, smart industries, e-health and wellness, and smart homes to name few. The Company has one operating segment, which is the design and marketing of semiconductor components for cellular wireless systems. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.

Share on Social Networks: